+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Pneumococcal Vaccine Market by Type (Conjugate Vaccines, Polysaccharide Vaccines), Indication (Bronchitis, Meningitis, Pneumonia), Product, Distribution - Forecast 2024-2030- Product Image
Global Pneumococcal Vaccine Market by Type (Conjugate Vaccines, Polysaccharide Vaccines), Indication (Bronchitis, Meningitis, Pneumonia), Product, Distribution - Forecast 2024-2030- Product Image
Sale

Global Pneumococcal Vaccine Market by Type (Conjugate Vaccines, Polysaccharide Vaccines), Indication (Bronchitis, Meningitis, Pneumonia), Product, Distribution - Forecast 2024-2030

  • PDF Icon

    Report

  • 197 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 4968848
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Pneumococcal Vaccine Market size was estimated at USD 10.41 billion in 2023, USD 11.34 billion in 2024, and is expected to grow at a CAGR of 8.98% to reach USD 19.02 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Pneumococcal Vaccine Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Pneumococcal Vaccine Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Pneumococcal Vaccine Market, highlighting leading vendors and their innovative profiles. These include Astellas Pharma Inc., Emergent BioSolutions Inc., GlaxoSmithKline PLC, Johnson & Johnson Services, Inc., Merck & Co., Inc., Pfizer Inc., Sanofi S.A., and Serum Institute of India Pvt. Ltd.

Market Segmentation & Coverage

This research report categorizes the Pneumococcal Vaccine Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Conjugate Vaccines
    • Polysaccharide Vaccines
  • Indication
    • Bronchitis
    • Meningitis
    • Pneumonia
    • Sepsis
  • Product
    • Pneumovax23
    • Prevnar 13
    • Synflorix
  • Distribution
    • Government Authorities
    • Non-Governmental Organizations
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Pneumococcal Vaccine Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Pneumococcal Vaccine Market?
  3. What are the technology trends and regulatory frameworks in the Pneumococcal Vaccine Market?
  4. What is the market share of the leading vendors in the Pneumococcal Vaccine Market?
  5. Which modes and strategic moves are suitable for entering the Pneumococcal Vaccine Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Pneumococcal Vaccine Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of pneumococcal contamination
5.1.1.2. Upsurge in the awareness programs regarding the proper vaccination
5.1.2. Restraints
5.1.2.1. High cost associated with the development of pneumococcal vaccines
5.1.3. Opportunities
5.1.3.1. Introduction of novel pneumococcal vaccines
5.1.3.2. New developments in adult vaccination
5.1.4. Challenges
5.1.4.1. Slow processing of clinical trials for the production of vaccine
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
6. Pneumococcal Vaccine Market, by Type
6.1. Introduction
6.2. Conjugate Vaccines
6.3. Polysaccharide Vaccines
7. Pneumococcal Vaccine Market, by Indication
7.1. Introduction
7.2. Bronchitis
7.3. Meningitis
7.4. Pneumonia
7.5. Sepsis
8. Pneumococcal Vaccine Market, by Product
8.1. Introduction
8.2. Pneumovax23
8.3. Prevnar 13
8.4. Synflorix
9. Pneumococcal Vaccine Market, by Distribution
9.1. Introduction
9.2. Government Authorities
9.3. Non-Governmental Organizations
10. Americas Pneumococcal Vaccine Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Pneumococcal Vaccine Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Pneumococcal Vaccine Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Astellas Pharma Inc.
14.1.2. Emergent BioSolutions Inc.
14.1.3. GlaxoSmithKline PLC
14.1.4. Johnson & Johnson Services, Inc.
14.1.5. Merck & Co., Inc.
14.1.6. Pfizer Inc.
14.1.7. Sanofi S.A.
14.1.8. Serum Institute of India Pvt. Ltd.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. PNEUMOCOCCAL VACCINE MARKET RESEARCH PROCESS
FIGURE 2. PNEUMOCOCCAL VACCINE MARKET SIZE, 2022 VS 2030
FIGURE 3. PNEUMOCOCCAL VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. PNEUMOCOCCAL VACCINE MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. PNEUMOCOCCAL VACCINE MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. PNEUMOCOCCAL VACCINE MARKET DYNAMICS
FIGURE 7. PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
FIGURE 8. PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2022 VS 2030 (%)
FIGURE 10. PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
FIGURE 12. PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2022 VS 2030 (%)
FIGURE 14. PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 16. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 18. UNITED STATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC PNEUMOCOCCAL VACCINE MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC PNEUMOCOCCAL VACCINE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 23. PNEUMOCOCCAL VACCINE MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 24. PNEUMOCOCCAL VACCINE MARKET SHARE, BY KEY PLAYER, 2022
List of Tables
TABLE 1. PNEUMOCOCCAL VACCINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. PNEUMOCOCCAL VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. PNEUMOCOCCAL VACCINE MARKET SIZE, BY POLYSACCHARIDE VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 9. PNEUMOCOCCAL VACCINE MARKET SIZE, BY BRONCHITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. PNEUMOCOCCAL VACCINE MARKET SIZE, BY MENINGITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. PNEUMOCOCCAL VACCINE MARKET SIZE, BY PNEUMONIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. PNEUMOCOCCAL VACCINE MARKET SIZE, BY SEPSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 14. PNEUMOCOCCAL VACCINE MARKET SIZE, BY PNEUMOVAX23, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. PNEUMOCOCCAL VACCINE MARKET SIZE, BY PREVNAR 13, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. PNEUMOCOCCAL VACCINE MARKET SIZE, BY SYNFLORIX, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 18. PNEUMOCOCCAL VACCINE MARKET SIZE, BY GOVERNMENT AUTHORITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. PNEUMOCOCCAL VACCINE MARKET SIZE, BY NON-GOVERNMENTAL ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 31. BRAZIL PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 32. BRAZIL PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 33. CANADA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 34. CANADA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 35. CANADA PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 36. CANADA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 37. MEXICO PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 38. MEXICO PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 39. MEXICO PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 40. MEXICO PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 46. ASIA-PACIFIC PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 47. ASIA-PACIFIC PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 48. ASIA-PACIFIC PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 50. ASIA-PACIFIC PNEUMOCOCCAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 51. AUSTRALIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 52. AUSTRALIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 53. AUSTRALIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 54. AUSTRALIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 55. CHINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 56. CHINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 57. CHINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 58. CHINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 59. INDIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 60. INDIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 61. INDIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 62. INDIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 63. INDONESIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 64. INDONESIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 65. INDONESIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 66. INDONESIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 67. JAPAN PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 68. JAPAN PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 69. JAPAN PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 70. JAPAN PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 71. MALAYSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 72. MALAYSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 73. MALAYSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 74. MALAYSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 75. PHILIPPINES PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 76. PHILIPPINES PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 77. PHILIPPINES PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 78. PHILIPPINES PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 79. SINGAPORE PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 80. SINGAPORE PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 81. SINGAPORE PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 82. SINGAPORE PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 83. SOUTH KOREA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 84. SOUTH KOREA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 85. SOUTH KOREA PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 86. SOUTH KOREA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 87. TAIWAN PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 88. TAIWAN PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 89. TAIWAN PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 90. TAIWAN PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 91. THAILAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 92. THAILAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 93. THAILAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 94. THAILAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 95. VIETNAM PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 96. VIETNAM PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 97. VIETNAM PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 98. VIETNAM PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 104. DENMARK PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 105. DENMARK PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 106. DENMARK PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 107. DENMARK PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 108. EGYPT PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 109. EGYPT PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 110. EGYPT PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 111. EGYPT PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 112. FINLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 113. FINLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 114. FINLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 115. FINLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 116. FRANCE PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 117. FRANCE PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 118. FRANCE PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 119. FRANCE PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 120. GERMANY PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 121. GERMANY PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 122. GERMANY PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 123. GERMANY PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 124. ISRAEL PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 125. ISRAEL PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 126. ISRAEL PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 127. ISRAEL PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 128. ITALY PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 129. ITALY PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 130. ITALY PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 131. ITALY PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 132. NETHERLANDS PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 133. NETHERLANDS PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 134. NETHERLANDS PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 136. NIGERIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 138. NIGERIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 139. NIGERIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 140. NORWAY PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 141. NORWAY PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 142. NORWAY PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 143. NORWAY PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 144. POLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 145. POLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 146. POLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 147. POLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 148. QATAR PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 149. QATAR PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 150. QATAR PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 151. QATAR PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 160. SOUTH AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 164. SPAIN PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 165. SPAIN PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 166. SPAIN PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 167. SPAIN PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 168. SWEDEN PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 169. SWEDEN PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 170. SWEDEN PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 171. SWEDEN PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 172. SWITZERLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 173. SWITZERLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 174. SWITZERLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 175. SWITZERLAND PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 176. TURKEY PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 177. TURKEY PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 178. TURKEY PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 179. TURKEY PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 184. UNITED KINGDOM PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM PNEUMOCOCCAL VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 188. PNEUMOCOCCAL VACCINE MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 189. PNEUMOCOCCAL VACCINE MARKET SHARE, BY KEY PLAYER, 2022
TABLE 190. PNEUMOCOCCAL VACCINE MARKET LICENSE & PRICING

Companies Mentioned

  • Astellas Pharma Inc.
  • Emergent BioSolutions Inc.
  • GlaxoSmithKline PLC
  • Johnson & Johnson Services, Inc.
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • Serum Institute of India Pvt. Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages197
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 11.34 Billion
Forecasted Market Value ( USD ) by 2030 $ 19.02 Billion
Compound Annual Growth Rate8.9%
Regions CoveredGlobal
No. of Companies Mentioned8

Related Topics

Related Reports

Pneumococcal Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 - Product Image

Pneumococcal Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

  • Report
  • 178 Pages
  • Global
From
Pneumococcal Vaccines Market : Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030 - Product Image

Pneumococcal Vaccines Market : Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030

  • Report
  • 180 Pages
  • Global
From
Pneumococcal Vaccine Global Market Report 2024 - Product Image

Pneumococcal Vaccine Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Pneumococcal Vaccine Market Report and Forecast 2024-2032 - Product Image

Pneumococcal Vaccine Market Report and Forecast 2024-2032

  • Report
  • 160 Pages
  • Global
From
Global Pneumococcal Vaccine Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis - Product Image

Global Pneumococcal Vaccine Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

  • Report
  • 213 Pages
  • Global
From

About the Pneumococcal Vaccine Market

The Pneumococcal Vaccine is a type of vaccine used to protect against infection caused by the bacterium Streptococcus pneumoniae. It is used to prevent a range of illnesses, including pneumonia, meningitis, and sepsis. The vaccine is typically administered to infants and young children, as well as adults who are at an increased risk of infection. It is also recommended for adults over the age of 65. The Pneumococcal Vaccine market is a subset of the larger Vaccines market. It is a highly competitive market, with a number of companies offering different types of vaccines. These companies are typically involved in the research, development, and production of the vaccines. They also provide support services such as distribution, marketing, and education. Some of the companies in the Pneumococcal Vaccine market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and Novartis. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.